Dentin Hypersensitivity, Non-carious Cervical Lesions, Gingival Recession Localized Moderate
Conditions
Keywords
Dentin Hypersensitivity, Laser, Olinano Seal, Dual Treatment
Brief summary
The aim of the study is to assess the effect of polymeric nano calcium fluoride Varnish (Oli-NANO seal), 976 nm diode laser solely and combination of both therapies in the treatment of dentin hypersensitivity
Interventions
OTHEROlinano seal
The OliNANO seal is "varnish-like" shield which is based on nanotechnology that allows an optimum adhesion to enamel and dentin, it could be used as an effective desensitizing agent by forming a protective layer that occludes the dentinal tubules which can be effective for a year as mentioned by the manufacturer. Polymeric nano calcium fluoride varnish consists of four main components, silicone polymer, NANO-fluorapatite, nano-calcium fluoride and amine fluoride (Olaflur)
DEVICEDiode Laser
increase in the metabolic activity of odontoblasts. Thus, obliteration of the dentinal tubules and formation of tertiary dentin.
OTHEROlinano seal and Diode Laser
Combined methods have been also evaluated in some previous studies. It showed more effect in reducing Dentin hypersensitivity than using every treatment solely
Sponsors
Faculty of Dental Medicine for Girls
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
30 Years to 50 Years
Healthy volunteers
Yes
Inclusion criteria
* Medically free * Non-smokers * Co-operative patients who will be interested in participating in the study and willing to sign the informed consent. * Availability of patients for 1 year
Exclusion criteria
* Patients currently using analgesic, anti-inflammatory medications, sedatives, tranquilizers, anticonvulsants, or any other medications that could potentially alter pain perception. * Patients undergoing orthodontic treatment. * Patients using desensitizing toothpaste * Patients receiving dentin hypersensitivity (DH) treatment * Pregnant or lactating women * Patients have high consumption of sour and acidic food * Patients who had undergone professional desensitizing therapy during the previous 3 months.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain severity | Before the treatment (Baseline), after the first session (T1), second session (T2) will be done after a week from the first session, after 3 months (T3), 6 months (T6), 9 months (T9) and 12 months (T12) | The pain will be assessed using the (VAS) scale. The VAS is a scale that allows the patient to self-assess the pain felt by means of a line in which the patient marks the pain level "no pain" to the "maximum pain". 0: low pain, 1 - 3: moderate pain: 4 - 6, intense pain: 7 - 9, extremely intense pain: 10 |
Countries
Egypt
Outcome results
None listed